Published in J Cell Biol on December 01, 1984
Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci U S A (1985) 3.41
The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J Cell Biol (1987) 3.22
Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J (1986) 2.35
Assembly of Weibel-Palade body-like tubules from N-terminal domains of von Willebrand factor. Proc Natl Acad Sci U S A (2008) 1.81
Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest (1985) 1.76
Substructure of human von Willebrand factor. J Clin Invest (1985) 1.55
Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases. J Immunol (2007) 1.37
Folding and oligomerization of influenza hemagglutinin in the ER and the intermediate compartment. EMBO J (1995) 1.34
Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. J Cell Biol (1986) 1.34
Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids. J Cell Biol (1991) 1.34
Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood (2011) 1.33
Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition. PLoS Pathog (2009) 1.33
Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. Am J Pathol (1989) 1.22
Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest (1987) 1.22
Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J (1993) 1.19
Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization. EMBO J (1990) 1.18
Identification of a novel high molecular weight protein preferentially expressed by sinusoidal endothelial cells in normal human tissues. J Cell Biol (1991) 1.11
Rab27a and MyRIP regulate the amount and multimeric state of VWF released from endothelial cells. Blood (2009) 1.11
Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci U S A (1987) 1.10
Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation. EMBO J (1987) 1.09
Two Cys residues essential for von Willebrand factor multimer assembly in the Golgi. Proc Natl Acad Sci U S A (2007) 1.09
The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII. Biochem J (1989) 1.08
Structure-function and regulation of ADAMTS-13 protease. J Thromb Haemost (2013) 1.06
The secretion of von Willebrand factor from endothelial cells; an increasingly complicated story. J Thromb Haemost (2013) 1.02
Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells. J Cell Biol (1989) 1.00
Intracellular maturation of mumps virus hemagglutinin-neuraminidase glycoprotein: conformational changes detected with monoclonal antibodies. J Virol (1986) 0.99
von Willebrand factor cleaved from endothelial cells by ADAMTS13 remains ultralarge in size. J Thromb Haemost (2009) 0.98
Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model. Arterioscler Thromb Vasc Biol (2012) 0.97
Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol (1994) 0.96
O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b. J Clin Invest (1992) 0.93
The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels. Blood (2013) 0.92
A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide. J Clin Invest (1989) 0.91
A prothrombin activator from Bothrops erythromelas (jararaca-da-seca) snake venom: characterization and molecular cloning. Biochem J (2003) 0.91
Inhibition of disulfide bonding of von Willebrand protein by monensin results in small, functionally defective multimers. J Cell Biol (1985) 0.91
Regulation of cellular communication by signaling microdomains in the blood vessel wall. Pharmacol Rev (2014) 0.90
Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. Am J Pathol (1996) 0.89
Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner. Arterioscler Thromb Vasc Biol (2013) 0.88
An explanation for minor multimer species in endothelial cell-synthesized von Willebrand factor. J Clin Invest (1986) 0.88
von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets. Proc Natl Acad Sci U S A (1989) 0.88
Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1995) 0.87
Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease. Proc Natl Acad Sci U S A (1996) 0.87
Role of von Willebrand factor in the haemostasis. Blood Transfus (2011) 0.87
Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain. J Clin Invest (1992) 0.86
Aftiphilin and gamma-synergin are required for secretagogue sensitivity of Weibel-Palade bodies in endothelial cells. Mol Biol Cell (2008) 0.86
The role of the 5'-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem J (1993) 0.83
Heterogeneous distribution of Weibel-Palade bodies and von Willebrand factor along the porcine vascular tree. Am J Pathol (1991) 0.83
Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease. Proc Natl Acad Sci U S A (1987) 0.83
The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor. Biochem J (1991) 0.83
Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain. J Clin Invest (1989) 0.82
Endothelial cell control of thrombosis. BMC Cardiovasc Disord (2015) 0.80
ADAMTS13 and von Willebrand factor interactions. Curr Opin Hematol (2015) 0.77
Proliferative response of human and minipig smooth muscle cells after coronary angioplasty to growth factors and platelets. Basic Res Cardiol (1997) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Synthesis and processing of asparagine-linked oligosaccharides. Annu Rev Biochem (1981) 11.44
The Golgi apparatus (complex)-(1954-1981)-from artifact to center stage. J Cell Biol (1981) 6.54
Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95
Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins. Cell (1977) 4.77
Processing mechanisms in the biosynthesis of proteins. Ann N Y Acad Sci (1980) 4.40
Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol (1982) 4.08
Comparative studies of intracellular transport of secretory proteins. J Cell Biol (1978) 3.62
Proteolytic processing in the biosynthesis of insulin and other proteins. Fed Proc (1974) 3.27
Synthesis of factor VIII antigen by cultured guinea pig megakaryocytes. J Clin Invest (1977) 3.14
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest (1980) 2.88
The factor VIII complex: structure and function. Blood (1981) 2.50
Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J Lab Clin Med (1974) 2.44
endo-beta-N-Acetylglucosaminidase from Streptomyces plicatus. Methods Enzymol (1978) 1.81
Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. J Biol Chem (1983) 1.77
Biosynthesis and processing of fibronectin in NIL.8 hamster cells. J Biol Chem (1979) 1.66
Biosynthesis of the human asialoglycoprotein receptor. J Biol Chem (1983) 1.65
The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta (1983) 1.45
Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly. J Biol Chem (1981) 1.43
Biosynthesis and axonal transport of rat neurohypophysial proteins and peptides. J Cell Biol (1977) 1.39
Similarities and differences between the fibronectins of normal and transformed hamster cells. J Biol Chem (1981) 1.34
Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1983) 1.32
Role of disulfide interchange enzyme in immunoglobulin synthesis. Biochemistry (1981) 1.28
Abnormal glycosylation of human fibronectin secreted in the presence of monensin. J Biol Chem (1983) 1.20
Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity. Blood (1980) 1.18
Biosynthesis and processing of rat haptoglobin. J Biol Chem (1983) 1.11
Subunit composition of oligomeric human von Willebrand factor. J Biol Chem (1983) 1.10
Effects of the ionophore monensin on type II collagen and proteoglycan synthesis and secretion by cultured chondrocytes. J Biol Chem (1982) 1.01
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell (1993) 6.05
Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell (1996) 4.52
Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med (1999) 4.44
Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol (1982) 4.08
PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell (1989) 3.95
The isolation of antibiotic-resistant salmonella from retail ground meats. N Engl J Med (2001) 3.55
A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A (1998) 3.54
Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J Exp Med (1998) 3.26
PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood (1989) 2.86
Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell (1986) 2.85
Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest (2000) 2.68
The combined role of P- and E-selectins in atherosclerosis. J Clin Invest (1998) 2.53
Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci U S A (1995) 2.37
Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA (1992) 2.27
A large glycoprotein lost from the surfaces of transformed cells. Ann N Y Acad Sci (1978) 2.11
High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem (1969) 2.09
Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc Natl Acad Sci U S A (1998) 2.06
Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood (2000) 2.05
Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1. Ann Intern Med (1993) 1.97
PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD15). Cell (1990) 1.96
NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci U S A (1998) 1.92
Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II. Science (1986) 1.91
Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A (2000) 1.90
Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest (1996) 1.81
Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain. J Biol Chem (1983) 1.77
Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779. J Thromb Haemost (2009) 1.76
Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest (1985) 1.76
Characterization of alpha 2 beta 2 and alpha 2 forms of kinesin. Biochem Biophys Res Commun (1991) 1.66
Defects in hemostasis in P-selectin-deficient mice. Blood (1996) 1.64
Absence of P-selectin delays fatty streak formation in mice. J Clin Invest (1997) 1.63
P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med (2000) 1.61
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60
P-Selectin and platelet clearance. Blood (1998) 1.56
Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. Proc Natl Acad Sci U S A (1999) 1.55
Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation (2000) 1.55
Adhesion molecules--Part II: Blood vessels and blood cells. N Engl J Med (1996) 1.54
Role of endothelial selectins in wound repair. Am J Pathol (1997) 1.50
The P-selectin, tissue factor, coagulation triad. J Thromb Haemost (2005) 1.49
Reduced recruitment of inflammatory cells in a contact hypersensitivity response in P-selectin-deficient mice. J Exp Med (1995) 1.47
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
Domain structure of fibronectin and its relation to function. Disulfides and sulfhydryl groups. J Biol Chem (1979) 1.46
Platelet-endothelial interactions in inflamed mesenteric venules. Blood (1998) 1.46
Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol Biol Cell (1993) 1.45
P-selectin and E-selectin. Distinct but overlapping leukocyte ligand specificities. J Biol Chem (1992) 1.44
Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early inflammatory responses. J Cell Biol (1998) 1.43
Detection of serum fibrinogen and fibrin degradation products. Comparison of six technics using purified products and application in clinical studies. Am J Med (1971) 1.41
Enhancement of fibrinolysis in vitro by ultrasound. J Clin Invest (1992) 1.41
Acquired "storage pool disease" of platelets associated with circulating antiplatelet antibodies. Am J Med (1974) 1.40
Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences. AJR Am J Roentgenol (1990) 1.39
Thrombogenic factors and recurrent coronary events. Circulation (1999) 1.38
Unusual anemias. Am J Hematol (1997) 1.38
ApoE deficiency compromises the blood brain barrier especially after injury. Mol Med (2001) 1.38
P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest (1993) 1.37
von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies. Blood (1994) 1.35
Similarities and differences between the fibronectins of normal and transformed hamster cells. J Biol Chem (1981) 1.34
Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor. J Cell Biol (1986) 1.34
Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood (2001) 1.33
How platelets safeguard vascular integrity. J Thromb Haemost (2011) 1.32
The size of human factor VIII heterodimers and the effects produced by thrombin. Biochim Biophys Acta (1986) 1.31
CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood (1993) 1.28
High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. J Biol Chem (1969) 1.28
Adhesion molecules--Part 1. N Engl J Med (1996) 1.27
Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies. Ann N Y Acad Sci (1965) 1.27
Characterization of Tn1546 in vancomycin-resistant Enterococcus faecium isolated from canine urinary tract infections: evidence of gene exchange between human and animal enterococci. J Clin Microbiol (2002) 1.27
A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg (1994) 1.26
Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med (1977) 1.26
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A (2001) 1.25
P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells. J Cell Biol (1992) 1.25
von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood (1987) 1.25
The food safety perspective of antibiotic resistance. Anim Biotechnol (2002) 1.22
Relationships between microfilaments, cell-substratum adhesion, and fibronectin. Cold Spring Harb Symp Quant Biol (1982) 1.22
Fibrin induces release of von Willebrand factor from endothelial cells. J Clin Invest (1987) 1.22
Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly. Proc Natl Acad Sci U S A (1992) 1.20
Blood cell dynamics in P-selectin-deficient mice. Blood (1995) 1.19
Infection-mediated early-onset periodontal disease in P/E-selectin-deficient mice. J Clin Periodontol (2001) 1.18
Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity. Blood (1980) 1.18
Topological arrangement of the major structural features of fibronectin. J Biol Chem (1980) 1.18
Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection. Ann Intern Med (1986) 1.17
Characterization of a novel adhesion function blocking monoclonal antibody to rat/mouse P-selectin generated in the P-selectin-deficient mouse. Hybridoma (1997) 1.17
Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin. J Bone Joint Surg Am (1997) 1.16
Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins. J Clin Invest (1996) 1.15
Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost (2009) 1.14
The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med (1979) 1.14
Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc Natl Acad Sci U S A (1987) 1.10
Structural studies of the functional heterogeneity of von Willebrand protein polymers. Blood (1981) 1.10
Standard nomenclature for factor VIII and von Willebrand factor: a recommendation by the International Committee on Thrombosis and Haemostasis. Thromb Haemost (1985) 1.10
In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls. J Biol Chem (1989) 1.10
Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation. Infect Immun (1996) 1.10
Electron microscopy of human factor V and factor VIII: correlation of morphology with domain structure and localization of factor V activation fragments. Proc Natl Acad Sci U S A (1990) 1.09
Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation. Infect Immun (1997) 1.09
Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase. Circulation (1985) 1.08
Requirement for both D domains of the propolypeptide in von Willebrand factor multimerization and storage. Thromb Haemost (1993) 1.08
Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int (1996) 1.08